Insider · CIK 0001212725
Cynthia Augustine
Files at REVG (REV Group, Inc.). First filing -, latest -.
In brief
Cynthia Augustine files SEC Form 4 as director at REVG (REV Group, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Cynthia Augustine has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 2, 2026 | REVG REV Group, Inc. | DDisposition to issuer Common Stock | -5,411 | $0.00 | $0 | 2,105 | Feb 2, 2026 |
| Feb 2, 2026 | REVG REV Group, Inc. | DDisposition to issuer Common Stock | -2,105 | $0.00 | $0 | 0 | Feb 2, 2026 |
| Dec 3, 2025 | REVG REV Group, Inc. | AGrant or award Common Stock | +2,105 | $0.00 | $0 | 7,516 | Dec 5, 2025 |
| Dec 5, 2024 | REVG REV Group, Inc. | AGrant or award Common Stock | +3,611 | $0.00 | $0 | 5,411 | Dec 9, 2024 |
Questions about Cynthia Augustine
Answered from the filings on this page, as of the latest one.
Is Cynthia Augustine buying or selling?
Cynthia Augustine has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Cynthia Augustine's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Cynthia Augustine has 0.
Where does Cynthia Augustine file Form 4?
Cynthia Augustine has filed Form 4 at REVG (REV Group, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.